Clinical Trials Logo

Atrial Fibrillation clinical trials

View clinical trials related to Atrial Fibrillation.

Filter by:

NCT ID: NCT00239226 Completed - Atrial Fibrillation Clinical Trials

Electrophysiologically Guided PAcing Site Selection Study

EPASS
Start date: November 2005
Phase: Phase 4
Study type: Interventional

This study is a long-term, prospective, and controlled evaluation of the incidence of persistent atrial fibrillation (AF) in patients with severe intra-right atrial conduction delay paced with preventive algorithms at the interatrial septum (IAS) versus right atrial appendage (RAA).

NCT ID: NCT00238706 Completed - Atrial Fibrillation Clinical Trials

Use of Radiofrequency Ablation to Eliminate Continuous Atrial Fibrillation in Patients Undergoing Mitral Valve Surgery

Start date: December 2001
Phase: N/A
Study type: Interventional

The aim of this prospective randomized clinical trial was to evaluate the early and late outcome following left atrial radiofrequency ablation during MV surgery for the treatment of continuous atrial fibrillation and to assess the functional effects of restoration of sinus rhythm.

NCT ID: NCT00233441 Completed - Atrial Fibrillation Clinical Trials

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter

MAIA
Start date: December 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Double blind study to evaluate the efficacy and tolerability of SSR149744C and select a dose to be further investigated in the maintenance of sinus rhythm after electrical, pharmacological or spontaneous conversion of AF/AFL.

NCT ID: NCT00232310 Completed - Atrial Fibrillation Clinical Trials

Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr

CORYFEE
Start date: October 2005
Phase: Phase 2
Study type: Interventional

Double blind study to assess versus placebo the efficacy of SSR149744C for the conversion of atrial fibrillation/flutter to sinus rhythm at the time of the planned electrical cardioversion.

NCT ID: NCT00232245 Completed - Atrial Fibrillation Clinical Trials

Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.

Start date: December 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate whether fish oil supplements may reduce the frequency and duration of paroxysmal atrial fibrillation episodes. Atrial fibrillation is a heart condition which effects a large percentage of the population . Atrial fibrillation is a condition frequently experienced by people who have had pacemakers inserted . Certain Pacemakers have sophisticated monitoring features that are able to recognise episodes of atrial fibrillation. Fish oil supplements may be of benefit to patients with heart problems.Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances. By interrogating pacemakers this study will investigate the effect of fish oil supplements on the frequency and duration of episodes of atrial fibrillation.

NCT ID: NCT00232232 Completed - Atrial Fibrillation Clinical Trials

Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia

Start date: September 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate whether fish oils may be of benefit to patients with certain heart rhythm disturbances called atrial fibrillation and atrial flutter. Atrial fibrillation and atrial flutter are two heart conditions that can be successfully treated in the hospital by an ablation (in the case of atrial flutter) or a cardioversion (in the case of atrial fibrillation). Ablation involves the application of high frequency energy waves to a particular spot in the heart. Cardioversion involves resetting the heart back to a normal rhythm with the use of an electric current. Fish oil supplements may be of benefit to patients with heart problems. Recent evidence suggests that fish oils may benefit those with rhythm disturbances.

NCT ID: NCT00232219 Completed - Atrial Fibrillation Clinical Trials

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion

Start date: January 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion. Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion. Cardioversion involves resetting the heart back to normal with the use of electric current. There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion. Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

NCT ID: NCT00231296 Completed - Atrial Fibrillation Clinical Trials

Safety and Efficacy of CryoCorâ„¢ Cryoablation for PAF

Start date: November 2004
Phase: N/A
Study type: Interventional

A multi-center, randomized, controlled study of cryoablation vs medical management for the treatment of PAF

NCT ID: NCT00224757 Completed - Stroke Clinical Trials

Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study

TIARA
Start date: September 2005
Phase: N/A
Study type: Interventional

In this multi centre pilot study we will perform TEE in patients with AF who are eligible for VKA treatment. TTE will be used as pre-screening: if TTE shows left atrial abnormalities or aortic plaque, patients will be excluded from randomisation. TEE will be performed in all other patients to detect or exclude complex aorta plaques or signs of left atrial stasis. Three hundred patients who do not have these features on TTE will be randomly assigned to treatment with aspirin or VKA. Follow-up will be 1 year.

NCT ID: NCT00215774 Completed - Atrial Fibrillation Clinical Trials

Flecainide-Short Long Study (Flec-SL)

Start date: March 2005
Phase: N/A
Study type: Interventional

A randomized trial to test the hypothesis that short-term pharmacological reversal of electrical remodeling after cardioversion is equally efficient to prevent recurrent atrial fibrillation as standard long-term antiarrhythmic therapy.